Jnana Therapeutics logo

Jnana Therapeutics

92 employees · est. 2017 · Boston, United States

VS
Locanabio, Inc. logo

Locanabio, Inc.

Creating RNA-targeting gene therapies to treat devastating diseases

7 employees · est. 2016 · San Diego, United States

Locanabio, Inc. is the older company (2017 vs 2016); Jnana Therapeutics is the larger of the two.

Side-by-Side Comparison

Jnana Therapeutics Locanabio, Inc.
Founded
2017 2016 older
Headquarters
Boston, United States San Diego, United States
Employees
92 larger 7
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health Care, Health and Wellness
Funding Stage
Series C Series B
Total Funding
$207.00M $155.55M
Funding Rounds
3 3
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Drug Discovery, Clinical-stage, Rare Diseases, Immune-mediated Diseases, Small Molecule Drugs, Metabolic Diseases, Phenylketonuria, Chemoproteomics, Allosteric Site Targeting, SLC6A19, Boston-based, Investment-backed, Scientific Leadership, Bain Capital Life Sciences RNA-targeting Gene Therapy, Genetic Medicine, Neurodegenerative Diseases, Neuromuscular Diseases, Rare Genetic Diseases, RNA Biology, Gene Editing, Genomic Medicine, RNA-mediated Disease, Drug Development, Neurological Disorders
Website
jnanatx.com locanabio.com
Jnana Therapeutics logo

About Jnana Therapeutics

Jnana Therapeutics is a clinical-stage biotechnology company utilizing its next-generation chemoproteomics RAPID platform to discover medications for highly validated, challenging-to-drug targets, addressing diseases with high unmet need. The company's focus lies in developing first- and best-in-cla...

Locanabio, Inc. logo

About Locanabio, Inc.

Locanabio, Inc., founded in 2016, is at the forefront of developing RNA-targeting gene therapies to address significant unmet medical needs. Their innovative approach focuses on correcting disease-causing RNA, utilizing a proprietary platform that includes advanced systems like snRNA, Cas13d, and PU...

We will tell you when either one moves

BounceWatch watches Jnana Therapeutics and Locanabio, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Jnana Therapeutics and Locanabio, Inc. — by email.

Frequently Asked Questions

Jnana Therapeutics. Locanabio, Inc. — Creating RNA-targeting gene therapies to treat devastating diseases. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Jnana Therapeutics has raised $207.00M while Locanabio, Inc. has raised $155.55M.
Jnana Therapeutics and Locanabio, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Jnana Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Jnana Therapeutics on 12 Sep 2024, and Locanabio, Inc. on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes